MedicaidPrior AuthHigh impact
KMAP BULLETIN: Pharmaceutical Prior Authorization March 2025 Updates
Kansas Medicaid (KanCare)·KS · Oncology, Dermatology, Cardiology +4 more·Provider Bulletin
Effective date
Mar 1, 2025
We identified it
Jun 21, 2026
Summary
Kansas Medicaid (KMAP) is implementing new prior authorization requirements for multiple medications in March 2025. Some medications will require Preferred Drug List (PDL) prior authorization starting March 1st, while others will need Clinical prior authorization beginning March 22nd.
Action Required
By March 1, 2025: Update prior authorization workflows for PDL medications (Clonidine XR, Lebrikizumab-lbkz, Macitentan/tadalafil, Nemolizumab-ilto, Roflumilast, Tapinarof, Vonoprazan). By March 22, 2025: Implement Clinical PA requirements for 23 additional medications including oncology drugs, dermatology treatments, and specialty medications. Billing team must verify authorization status before prescribing and inform providers of new requirements. Monitor KanCare Open Claims Resolution Log for MCO-specific implementation dates as timing may vary by plan.